Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2234-2243

  Singer, Stephan ^a   Malz, Mona ^a   Herpel, Esther ^a   Warth, Arne ^a   Bissinger, Michaela ^a   Keith, Martina ^a   Muley, Thomas ^b   Meister, Michael ^b   Hoffmann, Hans ^b   Penzel, Roland ^a   Gdynia, Georg ^a   Ehemann, Volker ^a   Schnabel, Philipp Albert ^a   Kuner, Ruprecht ^c   Huber, Peter ^d   Schirmacher, Peter ^a   Breuhahn, Kai ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Div of Molec Genome Analysis 0842   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAR UPSTREAM SEQUENCE ELEMENT BINDING PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN; STATHMIN; STATHMIN LINKE 3 PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; FUBP1 PROTEIN, HUMAN; HELICASE; SINGLE STRANDED DNA; SMALL INTERFERING RNA; STMN1 PROTEIN, HUMAN; STMN3 PROTEIN, HUMAN;

ADENOCARCINOMA; ARTICLE; CANCER TISSUE; CELL INVASION; CELL LINE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MICROTUBULE ASSEMBLY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL; TUMOR GENE; BIOSYNTHESIS; CANCER INVASION; CELL GROWTH; CELL MOTION; CELL SURVIVAL; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY;

CARCINOMA, NON-SMALL-CELL LUNG; CELL GROWTH PROCESSES; CELL MOVEMENT; CELL SURVIVAL; DNA HELICASES; DNA, SINGLE-STRANDED; DNA-BINDING PROTEINS; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; STATHMIN; TRANSFECTION;

EID: 65549110895     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3338     Document Type: Article

References (40)

1. Bhat KM, Setaluri V, Micro tubule-associated proteins as targets in cancer chemotherapy. Clin Cancer Res 2007;13:2849-54,
2. Desai A, Mitchison Tj. Microtubule polymerization dynamics. Annu Rev Cell Dev Biol 1997;13:83-117.
3. Cassimeris L, The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol 2002;14: 18-24,
4. Gavet O, Ozon S, Manceau V, Lawler S, Curmi P, Sobel A. The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network j Cell Sci 1998;111:3333-46.
5. Ozon S, Maucuer A, Sobel A The stathmin family- molecular and biological characterization of novel mammalian proteins expressed in the nervous system, Eur j Biochem 1997;248:794-806.
6. Bieche 1, Maucuer A, Laurendeau I, et al. Expression of stathmin family genes in human tissues: non- neural-restricted expression for SCLIP. Genomics 2003;81:400-10.
7. Howell B, Larsson N, Gullberg M, Cassimeris L. Dissociation of the tubulin-sequestering and microtubule catastrophe-promoting activities of oncoprotein 18/stathmin. Mol Biol Cell 1999;10:105-18.
8. Belmont LD, Mitchison Tj. Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules. Cell 1996;84:623-31.
9. Belletti B, Mcoloso MS, Schiappacassi M, et al. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell 2008;19:2003-13.
10. Niethammer P, Bastiaens P, Karsenti E. Statiimin- tubulin interaction gradients in motile and mitotic cells. Science 2004;303:1862-6.
11. Bieche I, Lachkar S, Becette V, et al. Overexpression of the stathmin gene in a subset of human breast cancer. Br j Cancer 1998;78:701-9.
12. Singer S, Ehemann V, Brauckhoff A, et al. Protumori- genic overexpression of stathmin/Opl8 by gain-of- function mutation in p53 in human hepatocarcino- genesis. Hepatology 2007;46:759-68.
13. Chen G, Wang H, Gharib TG, et al. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics 2003;2:107-16.
14. Alii E, Bash-Babula j, Yang JM, Hait WN. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 2002;62:6864-9.
15. Wang R, Dong K, Lin F, et al. Inhibiting proliferation and enhancing chemosensitivity to taxanes in osteosarcoma cells by RNA interference-mediated downregula- tion of stathmin expression. Mol Med 2007;13:567-75.
16. Lee HS, Lee DC, Park MH, et al. STMN2 is a novel target of β-catenin/TCF-mediated transcription in human hepatoma cells. Biochem Biophys Res Commun 2006;345:1059-67.
17. Alii E, Yang JM, Ford JM, Halt WK. Reversal of stathmin-mediated resistance to paclitaxel and vin bias- tine in human breast carcinoma cells. Mol Pharmacol 2007;71:1233-40.
18. Nussbaum T, Samarin J, Ehemann Vt et al. Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarci- nogenesis. Hepatology 2008;48:146-56.
19. Ivascu A, Kubbies M. Rapid generation of single- tumor spheroids for high-throughput cell function and toxicity analysis. J Biomol Screen 2006;11:922-32.
20. Prange W, Breuhahn K, Fischer F, et al. β-Catenin accumulation in the progression of human hepatocar- cinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. J Pathol 2003;201: 250-9.
21. Chen Y, Lin MC, Yao H, et al. Lentivirus-mediated UNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology 2007;46:200-8.
22. Kuner R, Muley T, Meister M, et al. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer 2009;63:32-8.
23. Cortes-Funes H. New treatment approaches for lung cancer and impact on survival. Semin Oncol 2002;29:26-9.
24. Battlehner CN, Saldiva PH Carvalho CR, et al. Nuclear/cytoplasmic ratio correlates strongly with survival in non-disseminated neuroendocrine carcinoma of the lung. Histopathology 1993;22:31-4,
25. Nishio K, Nakamura T, Koh Y, Kanzawa F, Tamura T, Saijo N. Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells. Cancer 2001;91:1494-9.
26. Liang XJ, Choi Y, Sackett DL, Park JK. Nitrosoureas inhibit the stathmin-mediated migration and invasion of malignant glioma cells. Cancer Res 2008;68:5267-72.
27. Kgo TT, Peng T, Liang XJ, et al. The lp-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas. J Natl Cancer Inst 2007;99:639-52.
28. Gavet Os El Messari S, Ozon S, Sobel A, Regulation and subcellular localization of the mierot.ubule~destabilizing stathmin family phosphoproteins in cortical neurons. J Neurosci Res 2002;68:535-50.
29. Charbaut E, Chauvin S, Enslen H, Zamaroezy S, Sobel A. Two separate motifs cooperate to target stathrnin- related proteins to the Golgi complex. J Cell Sci 2005; 118:2313-23.
30. Westermann S, Weber K. Post-translational modifications regulate microtubule function. Nat Rev Mol Cell Biol 2003;4:938-47.
31. Hubbert C, Guardiola A, Shao R, et al. HDAC6 is a microtubul e-associated deacetylase. Mature 2002;417: 455-8,
32. Thazhath R, Liu C, Gaertig j. Polyglycylation domain of tubulin maintains axonemal architecture and affects cytokinesis in Tetrahymena. Nat Cell Biol 2002; 4:256-9.
33. Ng DC, Lin BH, Lim CP, et al. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. j Cell Biol 2006;172:245-57.
34. Sahai E, Garcia-Medina R, Pouyssegur j, Vial E, Smurfl regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility, j Cell Biol 2007;176:35-42.
35. Briata P, Forcales SV, Ponassi M, et al, p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability' of select myogenic transcripts, Mol Cell 2005;20:891-903.
36. Kroll TT, Zhao WM, Jiang C, Huber PW. A homolog of FBP2/KSRP binds to localized mRNAs in Xenopus oocytes. Development 2002;129:5609-19.
37. Avigan MI, Strober B, Levens D. A far upstream element stimulates c-myc expression in undifferentiated leukemia cells. J Biol Chem 1990;265:18538-45.
38. Chung Hj, Levens D. c-myc expression: keep the noise downl Mol Cells 2005;20:157-66.
39. Chung Hj, Liu J, Dundr M, Nie Z, Sanford S, Levens D. FBPs are calibrated molecular tools to adjust gene expression. Mol Cell Biol 2006;26:6584-97.
40. Wong QW, Lung RR, Law PT, et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of stathminl. Gastroenterology 2008;135357-69.